Oskar Sienkiel

Oskar Sienkiel

Auto-generated profile, based on publicly available information

Oskar Sienkiel

7th Naval Hospital in Gdansk, Gdańsk, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
FKFilip Kieloch
Filip Kieloch
AFAgnieszka Fitas
Agnieszka Fitas
KKKarol Kanon
Karol Kanon
MSMathias Spitaleri
Mathias Spitaleri
WGWiktor Gąska
Wiktor Gąska
KDKarolina Dębek
Karolina Dębek
Introduction: Androgenetic alopecia (AGA) is a chronic progressive form of hair loss affecting a significant portion of the adult population. Although topical minoxidil has a proven efficacy, it is often associated with low adherence due to adverse effects and the inconvenience of use. Increasing attention is being paid to low-dose oral minoxidil (LDOM), which may represent a therapeutic alternative with a favorable safety profile. Purpose of The Work: The aim of this study was to assess the efficacy and safety of low-dose oral minoxidil (≤5 mg/day) in the treatment of androgenetic alopecia based on current clinical trial data. Material and Methods: A narrative literature review was conducted, including studies published in English between 2019 and 2024, concerning the efficacy and safety in patients with AGA. A total of 9 publications meeting the inclusion criteria were analyzed. Results: The analyzed studies demonstrated that LDOM increases both the number and diameter of hair in patients – in both men and women. The best results were observed at doses of 1-5 mg/day, although even very low doses (0.25 mg/day) yielded measurable effects. Adverse events were generally mild – most commonly hypertrichosis and cardiovascular symptoms (e.g., tachycardia), with incidence increasing with dose. Serious complications were rare and occurred primarily in patients with pre-existing heart disease. Conclusion: Low-dose oral minoxidil is an effective and well-tolerated treatment option for AGA. Further studies are needed to standarize dosing and assess the long-term safety of the therapy.

19 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
DSDawid Sewruk
Dawid Sewruk
KKKarol Kanon
Karol Kanon
MSMathias Spitaleri
Mathias Spitaleri
WGWiktor Gąska
Wiktor Gąska
OSOskar Sienkiel
Oskar Sienkiel
JGJulia Głowacka
Julia Głowacka
Introduction: Androgenetic alopecia (AGA) is a common hereditary condition characterized by progressive hair loss in both men and women. While not a direct health threat, AGA significantly affects psychological well-being due to the role of hair in self-image and perceived attractiveness. Dutasteride, initially approved for benign prostatic hyperplasia, has demonstrated greater efficacy than finasteride in treating AGA. Its use in mesotherapy may help reduce systemic side effects, although more research is needed to confirm safety and define optimal treatment protocols. Aim of study: To review current evidence on the efficacy and safety of dutasteride in the treatment of AGA and assess its potential as a therapeutic option. Methods and material: A literature search was conducted using PubMed and Scopus to identify relevant studies on the use of dutasteride in AGA. Results: Dutasteride 0.5 mg has shown superior efficacy compared to finasteride 1 mg and placebo in increasing hair count and shaft thickness in men with AGA. As a dual 5α-reductase inhibitor, dutasteride offers broader inhibition than finasteride, which targets only the type 2 isoenzyme. Higher doses, such as 2.5 mg, may yield even greater improvements. Mesotherapy with dutasteride appears to be well tolerated and may reduce systemic exposure, though evidence remains limited, and further studies are required to determine long-term safety and appropriate dosing. Conclusion: Although not officially approved for AGA, dutasteride demonstrates superior clinical efficacy compared to finasteride. Side effects, particularly regarding sexual function, appear similar; however, concerns about long-term risks such as depression and metabolic changes persist. These should be carefully considered in patient consultations. Mesotherapy may offer a safer delivery method, but more robust data are needed to support its widespread use.

20 August 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ZRZuzanna Rabczak
Zuzanna Rabczak
MNMarcin Narloch
Marcin Narloch
JKJakub Kamiński
Jakub Kamiński
JTJan Tomczyk
Jan Tomczyk
AŻAleksandra Żywicka
Aleksandra Żywicka
SKStanisław Kasprzak
Stanisław Kasprzak
Introduction: Obesity, a global health crisis, is a leading risk factor for chronic diseases like diabetes and cardiovascular disease. Its prevalence has more than doubled since 1990, straining healthcare systems. Management involves primary prevention (lifestyle interventions), secondary prevention (early detection and treatment), and tertiary prevention (managing established obesity via lifestyle changes, pharmacotherapy, or bariatric surgery). This review focuses on non-invasive treatment methods for obesity. Materials and methods: This review was conducted using PubMed and Google Scholar databases, focusing on recent systematic reviews, meta-analyses, and original research on non-surgical obesity treatments. Keywords included obesity, diet, exercise, pharmacotherapy, and education. Results: Recent findings suggest that combining reduced calorie intake with limited carbohydrate consumption can lead to more effective weight loss. Diets high in protein, particularly those containing whey, are beneficial for maintaining muscle mass during weight reduction. Medications such as GLP-1 receptor agonists support weight loss and metabolic health. Regular physical activity enhances fat loss and cardiovascular performance. Additionally, patient-focused strategies are essential for improving adherence and ensuring long-term success in obesity treatment. Conclusions: Effective obesity treatment requires combining personalized nutrition plan, physical activity, and medications. Prioritizing muscle preservation, protein intake, patient education, and stigma reduction enhances adherence and supports long-term weight and metabolic health outcomes.

19 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
AFAgnieszka Fitas
Agnieszka Fitas
FKFilip Kieloch
Filip Kieloch
DSDawid Sewruk
Dawid Sewruk
KKKarol Kanon
Karol Kanon
JGJulia Głowacka
Julia Głowacka
OSOskar Sienkiel
Oskar Sienkiel
Introduction: Vulvodynia is defined as chronic vulvar pain or discomfort lasting for at least three months without a clear somatic, infectious or neurological cause. Despite growing interest in the field of chronic pain in gynecology, vulvodynia remains poorly recognized and frequently marginalized in clinical practice. Material and methods: This article is based on a review of scientific literature available in databases such as PubMed and Scopus covering publications from 2000 to 2024 on vulvodynia and its impact on women’s quality of life. The analysis includes original studies, systematic reviews and clinical guidelines by the International Pelvic Pain Society (IPPS) and the International Society for the Study of Vulvovaginal Disease (ISSVD). Aim of study: The aim is to present the current state of knowledge on vulvodynia with a focus on its impact on women’s quality of life, including mental health, sexual functioning, social relationships and work activity. Conclusion: Vulvodynia remains a significant and underdiagnosed health problem with serious consequences for women’s quality of life. Increasing awareness and education among healthcare professionals are essential to improve diagnosis and management of vulvodynia. Promoting further research, expanding access to interdisciplinary care and integrating medical, psychological and physiotherapeutic interventions may contribute to more effective treatment, improved functioning of affected women and reduction of the broader socioeconomic burden associated with the disease.

18 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MJMateusz Jasiński
Mateusz Jasiński
JTJan Tomczyk
Jan Tomczyk
MSMichał Szalach
Michał Szalach
OSOskar Sienkiel
Oskar Sienkiel
KMKamila Mozga
Kamila Mozga
MNMarcin Narloch
Marcin Narloch
Gastric bezoars are defined as hard masses of undigested material located in the stomach lumen. Classifications mainly distinguish four types: phytobezoars, trichobezoars, pharmacobezoars, and lactobezoars. This article discusses conservative treatment methods that allow for the dissolution of masses or their reduction for easement of subsequent endoscopic treatment. A literature review was conducted using the PubMed database from the years 2015-2025. The symptoms of the disease are nonspecific and include abdominal pain and early satiety. If untreated, they can cause serious complications, including gastrointestinal bleeding, intestinal obstruction and intestinal necrosis. Diagnostic methods mainly include endoscopy, considered the gold standard in the diagnosis of bezoars. Conservative methods include enzymatic substances such as cellulase, papain, and N-acetylcysteine, or chemical substances such as Coca-Cola or bicarbonate. The presented forms of conservative treatment allow for the implementation of effective treatment without invasive procedures, thereby reducing the number of complications associated with the treatment. This article summarizes methods of conservative treatment for bezoars and serves as a tool for clinicians dealing with the therapy of this condition. As stated before, there are several forms of conservative treatment; however, their differentiation is mainly related to the etiology and origin of the lesion diagnosed in imaging studies. The manner in which the lesion develops determines the selection of the appropriate conservative treatment technique; however, an analysis of the available literature clearly shows that conservative treatment is an effective form of therapy for a selection of patients.

24 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
OSOskar Sienkiel
Oskar Sienkiel
JCJulia Czerwik
Julia Czerwik
MNMarcin Narloch
Marcin Narloch
JTJan Tomczyk
Jan Tomczyk
MJMateusz Jasiński
Mateusz Jasiński
KKKarol Kanon
Karol Kanon
Introduction. Tumors of the central nervous system (CNS) are relatively uncommon when compared with neoplasms arising in other organs and tissues of the human body. Among these rare entities, cerebellar liponeurocytoma represents one of the least frequently encountered tumor types. This neoplasm was originally described in 1978 by Bechtel and colleagues, who referred to it as a “mixed mesenchymal and neuroectodermal tumor” due to its unusual histological characteristics combining neuronal and lipomatous differentiation. Since that time, only a limited number of cases have been reported in the literature, underlining its exceptional rarity. In subsequent decades, advances in neuropathology and molecular diagnostics have allowed for more precise recognition of this lesion as a distinct clinicopathological entity. Within the World Health Organization (WHO) classification of tumors of the central nervous system published in 2016, cerebellar liponeurocytoma was formally designated as a grade II tumor. This reflects its generally indolent biological behavior but also acknowledges the significant potential for local recurrence following treatment. Aim of the Study. The aim of the study was to collect data about symptoms and immunoreactivity of cerebellar liponeurocytoma from published cases between 2014 and 2024. Materials and Methods. PubMed and Scopus databases were used to search for cerebellar liponeurocytoma cases. Result. Analyzing data from 32 cases of cerebellar liponeurocytoma, 11 men (34.4%) and 21 women (65.6%) were affected. The mean age was 42.9 ± 18.17 years. The youngest person was 6 years old and the oldest was 77. Two cases concerned patients under 18 years old. The most common tumor location was the posterior fossa (25/32 cases, 78.12%), followed by the ventricle area (4 cases, 12.5%) and the frontal lobe (1 case). The most common symptoms were headache (26/32, 81.25%), vomiting and nausea (15/32, 46.9%), gait disturbance (14/32, 44%), ataxia (3/32, 9.4%), paresthesia (3/32, 9.4%), and urge incontinence (1 case). Conclusion. Cerebellar liponeurocytoma is a rare but distinctive tumor of the central nervous system. The usual symptoms arise from the tumor's typical location in the cerebellum. Its clinical course, with atypical features, may pose significant management challenges. Further research into the tumor's molecular and genetic characteristics is needed to provide insights into optimizing management strategies and improving patient outcomes.